The last year saw the announcement of the world’s first precision medicine for prostate cancer and huge progress towards the development of a home urine test. Just some of the things that made 2019 one of the most innovative years in prostate cancer research history.
A prostate cancer urine test which has the potential to spot men with aggressive prostate cancer hit the headlines today. In partnership with Movember, we're funding the next stage of research to test this in a larger group of men.
A new immunotherapy treatment was in the news today, after a recent clinical trial showed it could extend the lives of some men with very advanced prostate cancer for up to two years.
Ahead of tonight's documentary we spoke to our ambassador Bill Turnbull about diagnosis, chemotherapy and the Turnbull/Fry effect.
The ATLANTA trial is testing a new way to treat advanced disease, targeting the initial tumour inside the prostate to slow the growth of other tumours around the body.
BLOG: From 'seek and destroy' radiotherapy to repurposing an ovarian cancer drug, it's been a week of big news from the world's biggest cancer research conference. Dr Matthew Hobbs gives his perspective on the latest in prostate cancer and what needs to happen next.
For the third time in four years, researchers have found a new treatment option to combine with hormone therapy and improve life expectancy for men with advanced prostate cancer.
BLOG: Dr Matthew Hobbs, our Acting Director of Research, shares his highlights from the latest research into more effective treatments for men with prostate cancer.
BLOG: Today is Blue Monday – supposedly the most depressing day of the year. But for some people coping with the fallout of prostate cancer, mental health can be a year-round struggle. Viral selfie star Kurt Jewson describes how post-traumatic stress disorder followed his diagnosis with advanced prostate cancer, and why he's learnt not to fight it.
The National Institute for Health and Care Excellence has recommended pre-biopsy mpMRI scans and a host of other improvements to diagnosis and treatments for prostate cancer become standard NHS practice across the UK. While we back the proposals, we're calling for enough scanners and trained staff to deliver them.